Liquidia LQDA
NASDAQ LQDA
$71.05 -4.28 (-5.68%)
At close: Aug 20, 2026 · 4:00 PM EDT

Liquidia (LQDA) Gross Margin (2020 - 2026)

Liquidia (LQDA) posted quarterly Gross Margin of 91.66% for Q1 2026, up 4028.0% year-over-year from 2.22% in Q1 2025, and down 2.92% quarter-over-quarter from 94.42% in Q4 2025.

Liquidia (LQDA) Gross Margin (2020 - 2026) Analysis & Trends

Liquidia's Gross Margin history runs 7 years deep, the most recent figure standing at 91.66% for Q1 2026.

  • In Q1 2026, Gross Margin rose 4028.0% year-over-year to 91.66%; the TTM figure through Mar 2026 stood at 93.13% (up 3504.0% YoY), while the FY2025 annual figure was 94.43%, up 3643.0% from the prior year.
  • Gross Margin for Q1 2026 stood at 91.66%, down from 94.42% in the prior quarter.
  • The five-year high for Gross Margin was 95.78% in Q3 2025, with the low at 50.64% in Q1 2024.
  • The 5-year median for Gross Margin is 81.34% (2022), against an average of 76.82%.
  • The sharpest annual moves came in 2024 and 2025: Gross Margin plunged 3480 bps in 2024, then jumped 4084 bps in 2025.
  • Liquidia's Gross Margin stood at 87.05% in 2022, then retreated by 10 bps to 78.08% in 2023, then sank by 31 bps to 53.58% in 2024, then jumped by 76 bps to 94.42% in 2025, then slipped by 3 bps to 91.66% in 2026.
  • Business Quant data shows LQDA's Gross Margin at 91.66% in Q1 2026, 94.42% in Q4 2025, and 95.78% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 43.83 Bn 42.86 Bn - -
2 Teva Pharmaceutical Industries 42.87 Bn 39.22 Bn 2.15 Bn 51.98%
3 Zoetis 31.41 Bn 29.73 Bn 1.05 Bn 42.63%
4 Takeda Pharmaceutical 28.55 Bn 22.75 Bn 5.10 Bn 66.66%
5 United Therapeutics 22.08 Bn 19.42 Bn 683.80 Mn 87.30%
6 Viatris 18.73 Bn 17.84 Bn 1.46 Bn 38.77%
7 Neurocrine Biosciences 15.44 Bn 15.05 Bn 935.80 Mn 97.58%
8 Elanco Animal Health 11.75 Bn 11.22 Bn 798.00 Mn 58.33%
9 Dr Reddys Laboratories 10.11 Bn 9.94 Bn - -
10 Liquidia 6.31 Bn 6.03 Bn 160.92 Mn 93.73%

Historic Data

Download Data
DateValue
Jun 30, 2026 93.73%
Mar 31, 2026 91.66%
Dec 31, 2025 94.42%
Sep 30, 2025 95.78%
Jun 30, 2025 85.38%
Mar 31, 2025 51.38%
Dec 31, 2024 53.58%
Sep 30, 2024 64.82%
Jun 30, 2024 59.20%
Mar 31, 2024 50.64%
Dec 31, 2023 78.08%
Sep 30, 2023 84.50%
Jun 30, 2023 85.98%
Mar 31, 2023 85.44%
Dec 31, 2022 87.05%
Sep 30, 2022 76.62%
Jun 30, 2022 81.34%
Mar 31, 2022 80.13%
Dec 31, 2021 77.42%
Sep 30, 2021 72.00%